SARS‐CoV‐2 RNA may rarely be present in a uterine cervix LBC sample at the asymptomatic early stage of COVID 19 disease
Open Access
- 25 May 2021
- journal article
- research article
- Published by Wiley in Cytopathology
- Vol. 32 (6), 766-770
- https://doi.org/10.1111/cyt.12995
Abstract
Objective Currently, it is thought that uterine cervix mucosal samples present a low risk of SARS-CoV-2 exposure. So far, there is no evidence of SARS-CoV-2 detection in Papanicolaou (Pap) smears. Nevertheless, clinicians could be exposed unaware to the coronavirus while performing and handling a Pap smear. We aimed to retrospectively evaluate the presence of SARS-CoV-2 RNA in cervical liquid-based cytology (LBC) samples in women who tested positive for a nasopharyngeal COVID-19 PCR test. Methods From our laboratory database, we identified patients with data on a cervical cancer screening LBC sample paired with a positive nasopharyngeal COVID-19 PCR test. Relevant LBC samples taken within an incubation period of 14 days and post-onset RNA shedding interval of 25 days were subsequently tested for SARS-CoV-2 RNA using RT-PCR tests. Results The study group consisted of 102 women. Of those, 23 LBC samples were tested. SARS-CoV-2 RNA was detected in one LBC sample from a 26-year-old asymptomatic woman taken six days before reporting headaches and knee arthralgia with a positive nasopharyngeal SARS-CoV-2 RT-PCR test. Conclusions It is possible to detect SARS-CoV-2 RNA in cervical LBC samples at an early asymptomatic stage of COVID-19. In general, this finding is infrequent in asymptomatic women who tested SARS-CoV-2 positive within an incubation of 14 days and a post-onset RNA shedding period of 25 days. We fully support the current thinking that cervical LBC samples from asymptomatic women pose a low risk of SARS-CoV-2 exposure and can be handled in the frame of good microbiological practice and procedures.Keywords
This publication has 21 references indexed in Scilit:
- Interventional cytopathology in the COVID‐19 eraCytopathology, 2020
- Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary PathologistsVirchows Archiv, 2020
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive studyThe Lancet Infectious Diseases, 2020
- Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID‐19) infection: Perspectives from TaiwanCancer Cytopathology, 2020
- Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS‐CoV‐2: An Italian institutional experience focusing on biosafety proceduresCancer Cytopathology, 2020
- Clinical and virological data of the first cases of COVID-19 in Europe: a case seriesThe Lancet Infectious Diseases, 2020
- Understanding COVID-19: what does viral RNA load really mean?The Lancet Infectious Diseases, 2020
- Viral dynamics in mild and severe cases of COVID-19The Lancet Infectious Diseases, 2020
- Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020Eurosurveillance, 2020
- Materno-fetal transmission of human coronaviruses: a prospective pilot studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008